Combination thymosin-α1 and interferon-α2b in the treatment of anti-HBe-positive chronic hepatitis B in Turkey

Hepato-Gastroenterology

Volumn 49, Issue 45, 2002, Pages 798-802

  Saruc, Murat ^a   Yuceyar, Hakan ^a   Kucukmetin, Nurten ^a   Demir, Mehmet Akif ^a   Kandiloglu, Ali Riza ^a  

^a Merkez Efendi Mah   (Turkey)

Author keywords

Chronic; Combination therapy; Hepatitis B; Interferon; Thymosin; Treatment

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA2B INTERFERON; HEPATITIS B(E) ANTIBODY; THYMOSIN ALPHA1; VIRUS DNA; ANTIVIRUS AGENT; DRUG DERIVATIVE; HEPATITIS B(E) ANTIGEN; IMMUNOLOGICAL ADJUVANT; THYMOSIN;

ADULT; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEPATITIS B; HUMAN; LIVER CIRRHOSIS; MALE; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT OUTCOME; TURKEY (REPUBLIC); DRUG COMBINATION; IMMUNOLOGY; MIDDLE AGED;

ADJUVANTS, IMMUNOLOGIC; ADULT; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HEPATITIS B E ANTIGENS; HEPATITIS B, CHRONIC; HUMAN; INTERFERON ALFA-2B; MALE; MIDDLE AGE; THYMOSIN; TREATMENT OUTCOME; TURKEY; HUMANS; MIDDLE AGED;

EID: 0036016778     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Natural history and therapy of chronic hepatitis B virus infection
2. A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B
3. The treatment of chronic viral hepatitis
4. A one-year trial of lamivudine for chronic hepatitis B
5. Identification and characterization of mutations in hepatitis B virus resistant to lamivudine
6. Hepatitis B therapy: The plot thickens
7. Lamivudine as initial treatment for chronic hepatitis B in the United States
8. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection
9. Hepatitis B virus mutants
10. A randomized controlled trial of lymphoblastoid interferon-alpha in patients with chronic hepatitis B lacking HBeAg
11. Interferon therapy for the anti-HBe positive form of chronic hepatitis B
12. Hepatitis B
13. Immunologic mechanisms is chronic viral hepatitis
14. Approaches to the treatment of hepatitis B virus and Delta-related liver disease
15. Thymalfasin. Clinical pharmacology and antiviral applications
16. Thymosin
17. Synergistic effect of thymosin alpha 1 and alpha beta-interferon on NK activity in tumor-bearing mice
18. In vivo recovery of natural killer cell activity by the association of thymosin a 1 and cytokines during cocaine administration
19. Combined treatment with thymosin alpha 1 and low-dose interferon-alpha after ifosfamide in non-small cell lung cancer: A phase II controlled trial
20. Treatment of chronic woodchuck hepatitis virus infection with thymosin alpha 1
21. Thymosin treatment of chronic hepatitis B: A placebo-controlled pilot trial
22. Efficacy of thymosin alpha1 in patients with chronic hepatitis B: A randomized, controlled trial
23. Thymosin alpha1 treatment of chronic hepatitis B: Results of a phase III multicentre, randomized, double-blind and placebo-controlled study
24. Prospectives on the treatment of chronic hepatitis B and chronic hepatitis C with thymic peptides and antiviral agents
25. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis
26. Drug therapy in patients with chronic type B hepatitis
27. The epidemiology of viral hepatitis in the United States
28. Current status of anti-HBV chemotherapy
29. A randomized, controlled trial of recombinant alpha-interferon therapy for chronic hepatitis B
30. Combination low-dose lymphoblastoid interferon and thymosin alpha 1 therapy in the treatment of chronic hepatitis B
31. Therapy of viral hepatitis
32. Hepatitis B e antigen negative chronic hepatitis B: From clinical recognition to pathogenesis and treatment
33. Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B
34. Long-term follow-up of patients with anti-HBe/HBV DNA-positive chronic hepatitis B treated for 12 months with lamivudine
35. A randomized controlled trial of thymosin alpha 1 versus interferon alpha treatment in patients with hepatitis B e antigen antibody - And hepatitis B virus DNA - Positive chronic hepatitis B